SEC Form D private-offering filing

Slate Medicines, Inc.

Name: Slate Medicines, Inc. - new SEC Form D private-offering filing, Boston, MA
Published: 2026-03-11

A new SEC Form D private-offering notice from Boston, MA, a $130,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Slate Medicines, Inc. site↗ Verified via SEC Form D

Biotech developing an anti-PACAP monoclonal antibody for the prevention of migraine and other headache disorders.

Filed 2026-03-11Filed to raise $130,000,000First money in 2026-02-17Raised so far $9,999,992HQ (as filed) Boston, MASector Biotech ✓Stage (inferred) LateCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified slatemedicines.com↗Named in the filing 6 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.